New York City; General Obligation; Insured Liquidity; Joint Criteria Dec 10

  • ID: 1753530
  • December 2010
  • Region: New York
  • Standard & Poors
1 of 3

Standard & Poor's Ratings Services assigned its 'AA' long-term rating, and stable outlook, to New York City's general obligation (GO) fiscal 2011 series F (F-1, F-2), G, and H bonds. At the same time, Standard & Poor's affirmed its 'AA' long-term rating, with a stable outlook, on the city's parity GO debt outstanding. Credit factors supporting the rating include our view of: New York City's substantial and diverse economic base. After a period of economic retrenchment caused by the recession, which affected employment, income, and the overall real estate market, economic trends have begun to stabilize. Although New York City continues to face significant issues, economic cycles are common. The city's comprehensive financial planning process, which has helped it effectively...

Companies mentioned in this report are:
- New York City

Action: New Rating

Standard and Poors RatingsXpress Credit Research provides in-depth coverage of international corporates, financial institutions, insurance companies, utilities, sovereigns and structured finance programs. RatingsXpress Credit Research lets users determine the credit rating of holdings and identify key factors underlying an issuer's creditworthiness, distinguishes the different risk exposures for new and existing deals, and provides an understanding of how their analysts interpret key regulatory, political and environmental events and their economic impact.

Research Type: Full Analysis

Note: Product cover images may vary from those shown
2 of 3

- New York City

Note: Product cover images may vary from those shown
3 of 3
Note: Product cover images may vary from those shown


  • Quick Help: This Credit Rating Report will be emailed to you.


If you have a more general question about our products please try our



Our Clients

  • Fluidigm Corporation
  • Apple, Inc.
  • CEVA Santé Animale
  • Abbott Laboratories Ltd.
  • Merck Group
  • Allergan Inc.
  • Pfizer, Inc.